Duncker Streett & Co’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-165
Closed -$2K 549
2020
Q3
$2K Hold
165
﹤0.01% 481
2020
Q2
$2K Hold
165
﹤0.01% 491
2020
Q1
$2K Hold
165
﹤0.01% 506
2019
Q4
$4K Buy
+165
New +$3.69K ﹤0.01% 516
2019
Q3
Sell
-295
Closed -$6K 448
2019
Q2
$6K Hold
295
﹤0.01% 511
2019
Q1
$6K Sell
295
-183
-38% -$3.47K ﹤0.01% 519
2018
Q4
$8K Hold
478
﹤0.01% 504
2018
Q3
$11K Sell
478
-377
-44% -$8.54K ﹤0.01% 508
2018
Q2
$19K Hold
855
﹤0.01% 470
2018
Q1
$15K Sell
855
-281
-25% -$4.95K ﹤0.01% 485
2017
Q4
$21K Sell
1,136
-108
-9% -$2.15K 0.01% 464
2017
Q3
$27K Buy
+1,244
New +$28.1K 0.01% 442

Other funds holding SBRA

Duncker Streett & Co's SBRA Position: Q4 2020 in Review

Duncker Streett & Co sold out of Sabra Healthcare REIT (SBRA) in Q4 2020, closing a stake of 165 shares — an estimated $2K sold.

Duncker Streett & Co first reported a position in SBRA in Q3 2017 and held it in 12 quarters. The position peaked at $27K in Q3 2017. 322 funds tracked by Wall St. Rank hold SBRA as of Q4 2020.

  • Duncker Streett & Co reported no remaining Sabra Healthcare REIT position as of Q4 2020 after selling out during the quarter.
  • Duncker Streett & Co sold 165 Sabra Healthcare REIT shares in Q4 2020, an estimated $2K.
  • Duncker Streett & Co first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 12 quarters.
  • Duncker Streett & Co's Sabra Healthcare REIT position peaked at $27K in Q3 2017.
  • 322 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2020.

Based on Duncker Streett & Co's 13F filing for Q4 2020, filed 2 Feb 2021.